Erythropoietic Protoporphyria: Clinical Trials

1 trial for Erythropoietic Protoporphyria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Erythropoietic Protoporphyria: new trials by email Literature Review of Erythropoietic Protoporphyria trials Research Report on Erythropoietic Protoporphyria

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
Afamelanotide 16mg implant - Erythropoietic Protoporphyria
Phase 1 / Phase 2CompletedClinuvel Europe Limited282024-03-072026-07-27

Narrower conditions

Protoporphyria, Erythropoietic (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Liver Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Porphyrias (1)  ·  Porphyrias, Hepatic (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Drug Implants (1)  ·  afamelanotide (1)

Sponsors

Clinuvel Europe Limited (1)

Countries

Belgium (1)  ·  Netherlands (1)